On the assessment of angiogenesis: it is time to change (go further) from an estimate to a measurement

• Autorzy: Grizzi F. , Chiriva-Internati M. , Yiu D.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2020
• Tom: 79
• Numer: 1
• Opis fizyczny: p.188-189,ref.

Twórcy

autor

Grizzi F.

• Department of Immunology and Inflammation, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy

autor

Chiriva-Internati M.

• Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer, Houston, TX, United States
• Kiromic Biopharma, Inc., Houston, TX, United States

autor

Yiu D.

• Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Bibliografia

• 1. Fidler IJ, Ellis LM. Neoplastic angiogenesis — not all blood vessels are created equal. N Engl J Med. 2004; 351(3): 215–216, doi: 10.1056/NEJMp048080, indexed in Pubmed: 15254281.
• 2. Grizzi F, Colombo P, Taverna G, et al. Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies? Appl Immunohistochem Mol Morphol. 2007; 15(2): 134–139, doi: 10.1097/01.pai.0000213105.18569.fa, indexed in Pubmed: 17525623.
• 3. Grizzi F, Russo C, Colombo P, et al. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer. 2005; 5: 14, doi: 10.1186/1471-2407-5-14, indexed in Pubmed: 15701176.
• 4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646–674, doi: 10.1016/j.cell.2011.02.013, indexed in Pubmed: 21376230.
• 5. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst. 2002; 94(12): 883–893, doi: 10.1093/jnci/94.12.883, indexed in Pubmed: 12072542.
• 6. Li H, Zhao B, Liu Y, et al. Angiogenesis in residual cancer and roles of HIF-1α, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer. Folia Morphol. 2020; 79(1): 71–78, doi: 10.5603/FM.a2019.0059, indexed in Pubmed: 31106843.
• 7. Morse MA, Sun W, Kim R, et al. The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res. 2019; 25(3): 912–920, doi: 10.1158/1078-0432.CCR-18-1254, indexed in Pubmed: 30274981.
• 8. Ogunwobi OO, Harricharran T, Huaman J, et al. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol. 2019; 25(19): 2279–2293, doi: 10.3748/wjg.v25.i19.2279, indexed in Pubmed: 31148900.
• 9. Taverna G, Grizzi F, Colombo P, et al. Is angiogenesis a hallmark of prostate cancer? Front Oncol. 2013; 3(6): 15–442, doi: 10.3389/fonc.2013.00015, indexed in Pubmed: 23390615.
• 10. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019; 380(15): 1450–1462, doi: 10.1056/NEJMra1713263, indexed in Pubmed: 30970190.

Identyfikatory

DOI

10.5603/FM.a2019.0096